Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Helin

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Acta Oto-Laryngologica|May 1, 1986
Cholesterol content in middle ear fluid in secretory otitis mediaT Palva, A Helin
Duodecim; Laaketieteellinen Aikakauskirja|May 11, 2002
[Treatments of benign prostatic hypertrophy and their cost-benefit relationship]P Rissanen, H Salo, A Helin-Salmivaara, et al.
Journal of Clinical Pharmacy and Therapeutics|April 7, 2005
Adoption of celecoxib and rofecoxib: a nationwide database studyA Helin-Salmivaara, R Huupponen, A Virtanen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 11, 2002
[Problem-based learning needed even in the further education]A Helin-Salmivaara, T Nikkarinen, T Heinänen, et al.
Journal of Clinical Pharmacy and Therapeutics|March 18, 2011
Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in FinlandA Helin-Salmivaara, M J Korhonen, T Alanen, et al.
Clinical Chemistry and Laboratory Medicine|December 18, 2016
Effects of apixaban on prothrombin time, activated partial thromboplastin time and anti-Xa assays: a European surveyTuukka A Helin, Anja Pakkanen, Riitta Lassila, et al.
Clinical Chemistry|February 5, 2013
Laboratory assessment of novel oral anticoagulants: method suitability and variability between coagulation laboratoriesTuukka A Helin, Anja Pakkanen, Riitta Lassila, et al.
Research and Practice in Thrombosis and Haemostasis|April 19, 2021
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated ThrombogramTuukka A Helin, Marja Lemponen, Riitta Lassila, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant TestingPaula Savola, Marja Lemponen, Lotta Joutsi-Korhonen, et al.
Thrombosis Journal|September 5, 2024
Circulating microRNAs targeting coagulation and fibrinolysis in patients with severe COVID-19Tuukka A Helin, Marja Lemponen, Katariina Immonen, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Acta Oto-Laryngologica|May 1, 1986
Cholesterol content in middle ear fluid in secretory otitis mediaT Palva, A Helin
Duodecim; Laaketieteellinen Aikakauskirja|May 11, 2002
[Treatments of benign prostatic hypertrophy and their cost-benefit relationship]P Rissanen, H Salo, A Helin-Salmivaara, et al.
Journal of Clinical Pharmacy and Therapeutics|April 7, 2005
Adoption of celecoxib and rofecoxib: a nationwide database studyA Helin-Salmivaara, R Huupponen, A Virtanen, et al.
Duodecim; Laaketieteellinen Aikakauskirja|April 11, 2002
[Problem-based learning needed even in the further education]A Helin-Salmivaara, T Nikkarinen, T Heinänen, et al.
Journal of Clinical Pharmacy and Therapeutics|March 18, 2011
Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in FinlandA Helin-Salmivaara, M J Korhonen, T Alanen, et al.
Clinical Chemistry and Laboratory Medicine|December 18, 2016
Effects of apixaban on prothrombin time, activated partial thromboplastin time and anti-Xa assays: a European surveyTuukka A Helin, Anja Pakkanen, Riitta Lassila, et al.
Clinical Chemistry|February 5, 2013
Laboratory assessment of novel oral anticoagulants: method suitability and variability between coagulation laboratoriesTuukka A Helin, Anja Pakkanen, Riitta Lassila, et al.
Research and Practice in Thrombosis and Haemostasis|April 19, 2021
Anticoagulated patients exhibit intact endogenous thrombin potential using ST Genesia unlike the Calibrated Automated ThrombogramTuukka A Helin, Marja Lemponen, Riitta Lassila, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant TestingPaula Savola, Marja Lemponen, Lotta Joutsi-Korhonen, et al.
Thrombosis Journal|September 5, 2024
Circulating microRNAs targeting coagulation and fibrinolysis in patients with severe COVID-19Tuukka A Helin, Marja Lemponen, Katariina Immonen, et al.
Pageof 3